- Author(s):
- Organization(s):
Alcon Research
Obtaining regulatory approval for changes during nasal spray drug product development.
For sponsors with nasal sprays in Phase III development, having knowledge of the necessary tests and possible in vitro alternatives to repeating clinical trials for the following potential product changes can save significant time and money.